lncRNA CASC2 Enhances ¹³¹I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155

Figure 3

Knockdown of CASC2 decreases ¹³¹I sensitivity in sensitive papillary thyroid cancer cells. (a, b) qRT-PCR detected the level of CASC2 in TPC-1, res-TPC-1, IHH-4, and res-IHH-4 cells. (c, d) qRT-PCR measured the abundance change of CASC2 in TPC-1 and IHH-4 cells after transfection of si-CASC2 or si-NC. (e, f) Cell viability and (g) apoptosis in TPC-1 and IHH-4 cells transfected with si-CASC2 or si-NC were analyzed after treatment of the indicated dose of ¹³¹I for 12 h. , , and .

(a)

(b)

(c)

(d)

(e)

(f)

(g)